Acumen Pharmaceuticals, Inc. Common Stock
ABOSRank #105Updated . Prices are snapshots and may be delayed.
Acumen Pharmaceuticals, Inc. Common Stock price chart
AI Outlook for Acumen Pharmaceuticals, Inc. Common Stock
Bearish posture- Long-term trend-91.6% vs 200-day average
- Medium-term trend-91.3% vs 50-day average
- Averages50-day below 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Acumen Pharmaceuticals, Inc. Common Stock performance
About Acumen Pharmaceuticals, Inc. Common Stock
Acumen Pharmaceuticals, Inc. Common Stock is a biotechnology company based in the United States, listed on NASDAQ since 2021 (ticker ABOS).
Its market capitalisation is $166 million, the #105 largest of the 119 stocks Air Radar has market-cap data for.
Acumen Pharmaceuticals, Inc. Common Stock market data
What is the price of Acumen Pharmaceuticals, Inc. Common Stock today?
Acumen Pharmaceuticals, Inc. Common Stock (ABOS) is at $0.21, −90.83% on the day.
What is the 52-week range of Acumen Pharmaceuticals, Inc. Common Stock?
Over the past year Acumen Pharmaceuticals, Inc. Common Stock has traded between $1.50 and $3.60. It is currently -61% of the way up that range.
What is the market cap of Acumen Pharmaceuticals, Inc. Common Stock?
Acumen Pharmaceuticals, Inc. Common Stock has a market capitalisation of $165,629,563, the #105 largest of the stocks Air Radar has market-cap data for.
Similar stocks
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.








